However, the release of HMGB1 from dying cancer cells is not solely consistent with the establishment of anti-tumor immune responses as redox modifications induced by the cell or in the extracellular milieu, which may alter and even attenuate its DAMP activities [42, 43]. This evidence concerns the gene HMGB1 and cancer.